AI digital twin developer Twin Health announced that it brought in a $53 million investment round, led by Maj Invest of Denmark.
Mountain View, California-based Twin Health says the funds can help accelerate its expansion. It hopes to widen its reach among health plans and clients in retail, healthcare, financial services, technology and manufacturing.
This fundraising follows landmark study results that found Twin Health’s AI digital twin is a highly effective treatment for diabetes and weight loss, without high-cost medications. That study was published in the New England Journal of Medicine Catalyst.
Twin Health says it built its real-time digital twin from thousands of data points across biomarkers, behaviors and preferences. It reflects not just a user’s metabolism but also habits in nutrition, sleep and physical activity. The technology provides continuous high-performance care for metabolic health by optimizing biology and behavior in unison.
By combining technology and dedicated human care teams, the AI model comes to life to help treat metabolic disease in real-time. Members receive daily personalized guidance and live coaching to help achieve their goals. Those could include lowering A1C, reaching a healthier weight or safely transitioning off medications, including GLP-1s.
“Traditional solutions have focused on just managing the disease,” said Jahangir Mohammed, founder and CEO of Twin Health. “Twin is different. We address the root causes of chronic metabolic diseases to improve and reverse diabetes. Members use their own biomarker data—not population averages — to create their own AI digital twin that guides them in a way that is engaging, precise, and sustainable. We believe metabolic health is a continuous condition, not an episodic event, and Twin delivers continuous, 24/7 guidance to meet that reality. We envision a future where everyone has an AI digital twin to improve their health and reduce healthcare spend.”
